BioCentury
ARTICLE | Distillery Therapeutics

Ophthalmic disease

June 13, 2018 6:18 PM UTC

In vitro, mouse and cell culture studies identified a mutant RHO-stabilizing compound that could help treat retinal degeneration and autosomal dominant retinitis pigmentosa (adRP). High throughput scr...

BCIQ Company Profiles

Case Western Reserve University

BCIQ Target Profiles

Rhodopsin (RHO) (OPN2)